A*STAR Outstanding Publications Award 2009, 2010, 2012, 2013 and 2014
A*STAR Patent Power Award 2009 and 2010
Singapore HEALTH Award (Platinum) 2012, (Gold) 2008 and 2010
Made-in-Singapore Rapid Test Kit Detects Dengue Antibodies from Saliva
IBN’s MedTech innovation simplifies diagnosis of infectious diseases
The IBN research team that developed this device comprises Executive Director Professor Jackie Y. Ying, Postdoctoral Fellow Dr Yi Zhang and Research Scientist Dr Jianhao Bai (from left to right).
January 29, 2015 – Finding out whether you have been infected with dengue may soon be as easy as spitting into a rapid test kit. The Institute of Bioengineering and Nanotechnology (IBN) of A*STAR has developed a paper-based disposable device that will allow dengue-specific antibodies to be detected easily from saliva within 20 minutes. This device is currently undergoing further development for commercialization.
IBN Executive Director Professor Jackie Y. Ying shared, “Our rapid diagnostic kit can detect a key dengue antibody from saliva that is present in early-stage secondary infection. The ability to differentiate between primary and secondary dengue infections makes it a valuable early diagnosis tool that would help to ensure timely treatment and proper care of patients.”
Delta-IBN Life Science and Diagnostics Lab Opens at Biopolis
Collaboration between Delta Group and Institute of Bioengineering and
Nanotechnology targets the global medical technology market
(From left) Mr. Lim Chuan Poh (Chairman, A*STAR), Mr. Ping Cheng (CEO, Delta), and Prof. Jackie Y. Ying (Executive Director, IBN) at the Official Opening of the Delta-IBN Life Science and Diagnostics Lab at the Biopolis.
January 14, 2015 – Delta Electronics INT’L (Singapore) and the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR today announced the official opening of the Delta-IBN Life Science and Diagnostics Lab at the Biopolis. The lab aims to develop next-generation infectious disease detection kits through collaborative research projects undertaken by Delta, IBN, and local universities. Mr. Lim Chuan Poh, Chairman of A*STAR, was the Guest-of-Honor and officiated the opening ceremony together with Mr. Ping Cheng, CEO of Delta Electronics, and Prof. Jackie Y. Ying, Executive Director of IBN.
The Delta-IBN Life Science and Diagnostics Lab brings together IBN’s strengths in medical diagnostics, microfluidic systems and biological assays, and Delta’s expertise in microelectronics, optical devices, and global operations. The lab will focus on developing enabling technologies for improved infectious disease detection and personalized medicine. Current diagnostics require a long processing time and extensive, specialized laboratory equipment, and the lab will develop portable miniaturized all-in-one systems to provide on-the-spot, real-time detection results.
Welcome Address by Prof Jackie Y. Ying, IBN Executive Director
Guest-of-Honor Speech by Mr Lim Chuan Poh, A*STAR Chairman
Second IBN International Symposium on Nanomedicine and Nanoassays in Singapore
IBN organized the 2nd IBN International Symposium (IBN-is) on December 8-9, 2014 at the Matrix, Biopolis. This year’s theme on Nanomedicine and Nanoassays’ represents two exciting areas that are set to transform healthcare and diagnostics.
The symposium featured 17 invited speakers from renowned institutions worldwide, 17 contributed oral and 56 poster presentations. 350 local and international delegates attended the two-day symposium.
A Special Forum for Students was held in the afternoon of December 9, where a distinguished panel shared personal insights from their careers in industry, academia and hospital, to inspire and encourage students to pursue careers in research.
To find out more, please visit: www.ibn-is.com.
IBN in the News
Delta, IBN Open Delta-IBN Life Science and Diagnostics Lab at Biopolis
Pharmabiz.com, 16 Jan 2015
Delta Electronics Opens Joint Diagnostics Lab in Singapore
Evertiq, 16 Jan 2015
Taiwan Firm Delta, A*Star Launches Diagnostics Lab in Singapore
BioSpectrum, 16 Jan 2015
Polyurethane-Coated Silica Particles with Broad-Spectrum Antibacterial Properties
Polymer Chemistry, (2015)
(IF: 5.368) article
Injectable Biodegradable Hydrogels from Vitamin D-Functionalized Polycarbonates for the Delivery of Avastin with Enhanced Therapeutic Efficiency against Metastatic Colorectal Cancer
(IF: 5.788) article
Antimicrobial Hydrogels: A New Weapon in the Arsenal Against Multidrug-Resistant Infections
Advanced Drug Delivery Reviews, 78 (2014) 46-62.
(IF: 12.707) article
Corporate Administration Positions